A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

Also Read: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks ... testimony that Zantac could cause cancer, as a federal judge did in 2022 for about 50,000 claims in Florida.

"Judge Medinilla resoundingly rejected GSK ... introducing expert testimony that Zantac can cause cancer, as a federal judge did in 2022 in about 50,000 claims centralized in Florida.

Although GSK has consented to the settlement, the firm has rejected any admission of guilt, citing an absence of "consistent or reliable evidence" connecting Zantac to cancer. Additionally ...

The plaintiffs claim that they developed cancer due to the medication Zantac, which is used to relieve ... "We also appreciate that the court rejected the defendants' improperly restrictive ...

Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer. The state’s highest ...

(Reuters) - GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness ...

GSK won a Florida state court lawsuit against a claim that its discontinued heartburn drug Zantac caused prostate cancer ... appeal to the Superior Court was rejected in July.

The crux of her argument and the claims made in the other suits is that the active ingredient in Zantac, called ranitidine, degrades into the cancer-causing substance NDMA, or nitrosodimethylamine.

If the state high court rejects the appeal, the Zantac lawsuits will ... that Zantac could cause cancer, as a federal judge did in 2022 for about 50,000 claims in Florida. These lawsuits depend ...